A Potential Challenger For AstraZeneca’s Blockbuster Lung Cancer Drug?
AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug. read more
AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug. read more
Oracle Corp. disclosed contracts and product enhancements, including Exadata Database Service on Exascale Infrastructure, easier management and pay-as-you-go pricing, and boosted employee experience. read more
Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting independent pharmacies nationwide. read more
Phoenix Motor Inc. (NASDAQ: PEV) rises premarket on launching autonomous robots for package pickup and delivery. AI-driven tech for contactless logistics. read more
Darden Restaurants reported a 6.2% YoY revenue increase to $3.158 billion for Q3, falling short of consensus. The company’s same-restaurant sales rose 0.7%, driven by acquisitions. Darden’s operating income grew 7.9%, and adjusted EPS of $2.80 surpassed expectations. read more
Tesla recalling 46,096 Cybertruck vehicles in the U.S. due to exterior panel safety issue. This adds to a series of recalls for the electric vehicle. read more
Short interest on SoundHound AI has risen by 18%, however, the CEO remained confident in the company’s growth prospects. read more
NYSE: QXO trading higher premarket after announcing merger with NASDAQ: BECN for $124.35 per share in cash. Tender offer extended until 3/31/2025. read more
A significant trading signal occurred for Broadcom stock, as it demonstrated a Power Inflow at $192.17, after which AVGO rose up to 3.2%. read more